Get started
Author

Christopher Drudge

Observed names: C. Drudge, Christopher Rudge, Drudge, Christopher
ORCID: 0000-0001-9721-3069
Observed ORCID: 0000-0001-9721-3069
OpenAlex ID: A5015109869
Efficacy classification of modern therapies in multiple sclerosis
2021 · Imtiaz A Samjoo, Evelyn Worthington, et al. · Journal of Comparative Effectiveness Research · 120
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
2020 · Imtiaz A Samjoo, Evelyn Worthington, et al. · Journal of Comparative Effectiveness Research · 68
Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis
2023 · Imtiaz A Samjoo, Christopher Drudge, et al. · Journal of Comparative Effectiveness Research · 67
Unmet Need in People with Psoriasis and Skin of Color in Canada and the United States
2022 · Geeta Yadav, Jensen Yeung, et al. · Dermatology and Therapy · 33
PDF
Estimates of healthcare utilisation and deaths from waterborne pathogen exposure in Ontario, Canada
2020 · Susan Lavinia Greco, Christopher Drudge, et al. · Epidemiology and Infection · 22
PDF
An approach to estimating the environmental burden of cancer from known and probable carcinogens: application to Ontario, Canada
2020 · Susan Lavinia Greco, Elaina MacIntyre, et al. · BMC Public Health · 21
PDF
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
2022 · Imtiaz A. Samjoo, Luisa Klotz, et al. · Multiple Sclerosis and Related Disorders · 17
Estimated Annual Deaths, Hospitalizations, and Emergency Department and Physician Office Visits from Foodborne Illness in Ontario
2018 · Christopher Drudge, Susan Greco, et al. · Foodborne Pathogens and Disease · 16
PDF
Exploring nighttime road traffic noise: A comprehensive predictive surface for Toronto, Canada
2018 · Christopher Drudge, James Johnson, et al. · Journal of Occupational and Environmental Hygiene · 12
PDF
Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis
2023 · Jaya Kala, Rebecca Nelson, et al. · ClinicoEconomics and Outcomes Research · 11
PDF
An evidence review and gap analysis for obstructive hypertrophic cardiomyopathy
2024 · Michael Butzner, Elise Aronitz, et al. · BMC Cardiovascular Disorders · 7
PDF
Network connectivity, between-study heterogeneity and timepoint challenges in generalized myasthenia gravis: a feasibility assessment of indirect treatment comparisons
2025 · Nils Erik Gilhus, Saiju Jacob, et al. · Journal of Comparative Effectiveness Research · 5
PDF
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons
2024 · Nicholas Riley, Christopher Drudge, et al. · Therapeutic Advances in Neurological Disorders · 4
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
2021 · Imtiaz A. Samjoo, Evelyn Worthington, et al. · Current Medical Research and Opinion · 4
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis
2026 · Saiju Jacob, Mahmoud Hashim, et al. · Advances in Therapy · 3
PDF
An overview of reviews with network meta-analyses comparing disease-modifying therapies for relapsing multiple sclerosis
2023 · Christopher Drudge, Imtiaz A Samjoo, et al. · Future Neurology · 3
Systematic review and network meta‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis
2022 · Christopher Drudge, Melody Zhao, et al. · Clinical and Experimental Neuroimmunology · 3
PDF
Sa2 Evidence Base for Joint Clinical Assessment: a Clinical Systematic Literature Review of Oav101 It and Comparators for Spinal Muscular Atrophy
2026 · Nicholas Riley, Grace McCarthy, et al. · Value in Health
Co154 Comparing 1.5% Ruxolitinib Cream and Other Therapies for Pediatric Patients With Atopic Dermatitis: a Systematic Literature Review and Network Meta-analysis
2026 · Vimal H. Prajapati, Kerri Purdy, et al. · Value in Health
Sa26 Feasibility of Indirect Treatment Comparisons for Oav101 It in Spinal Muscular Atrophy
2026 · Nicholas Riley, Almuth Marx, et al. · Value in Health
Evidentiary Burdens and the Recovery of Social Security Debts: Chaplin v Secretary, Department of Social Services (Cth)
2026 · Christopher Rudge, Darren O'Donovan · Sydney law review
PDF
SA79 Targeted Review and Gap Assessment for Refractory Metastatic Colorectal Cancer Without Liver Metastases
2025 · Christopher Drudge, Varun Bhardwaj, et al. · Value in Health
Abstract PO1-06-03: Efficacy of First-line Treatments for Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer: A Systematic Literature Review and Network Meta-analysis Feasibility Assessment
2024 · Priyanka Sharma, Chau Dang, et al. · Cancer Research
EPH59 An Evidence Gap Analysis of the Epidemiology and Burden of Obstructive Hypertrophic Cardiomyopathy
2023 · M. Butzner, E. Aronitz, et al. · Value in Health
PDF
Letter in reply
2021 · Imtiaz A Samjoo, Evelyn Worthington, et al. · Journal of Comparative Effectiveness Research
Works count: 29
Citation count: 416
H-index: 10
I10-index: 10
Year
Topic
Type